✦ LIBER ✦

Resting state EEG rhythms as network disease markers for drug discovery in Alzheimer's disease

✍ Scribed by Babiloni, Claudio; Infarinato, Francesco; Triggiani, Antonio I.; Lizio, Roberta; Percio, Claudio Del; Marzano, Nicola; Richardson, Jill C.

Book ID: 126872845
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 557 KB
Volume: 10
Category: Article
ISSN: 1740-6773
DOI: 10.1016/j.ddstr.2014.02.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cortical neural synchronization mechanis

Cortical neural synchronization mechanisms in Alzheimer's disease as revealed by resting state EEG rhythms: A window on cholinergic function?

✍ Babiloni, Claudio 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

65. Cortical sources of resting state EE

65. Cortical sources of resting state EEG rhythms reflect disease progression over 1year in mild cognitive impairment and Alzheimer’s disease patients

✍ Lizio, R.; Babiloni, C.; Percio, C. Del; Marzano, N.; Soricelli, A.; Salvatore, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Induced pluripotent stem cells as tools

Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease

✍ Ooi, Lezanne; Sidhu, Kuldip; Poljak, Anne; Sutherland, Greg; O’Connor, Michael D 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 375 KB

58. Cortical sources of resting state EE

58. Cortical sources of resting state EEG rhythms in Alzheimer’s disease patients are related to the integrity of structural brain connectivity as revealed by tractography: An EEG-DTI combined study

✍ Vecchio, F.; Carducci, F.; Piervincenzi, C.; Lizio, R.; Vernieri, F.; Ursini, F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Beta-secretase as a target for Alzheimer

Beta-secretase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors

✍ Francesca Mancini; Angela De Simone; Vincenza Andrisano 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 499 KB

Alzheimer's disease drug discovery: in v

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity

✍ Lublin, A.L.; Link, C.D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 517 KB